Podcasts

02/01/2012 New Approaches to Treating Dyskinesias

MJFF CEO Todd Sherer, PhD, discusses dyskinesias, and research leads toward new ways to treat them

12/08/2011 Hot Topics Call: Biomarkers and PPMI

On December 6, Mark Frasier and Ken Marek from the Institute of Neurodegenerative Disorders lead a discussion about biomarkers and PPMI.

11/29/2011 A Parkinson's Disease Vaccine

Dave Iverson spoke to Achim Schneeberger of AFFiRiS about PD01, a vaccine which targets alpha-synuclein.

11/29/2011 Teva Seeks Label Change for Azilect

MJFF's Brian Fiske discusses an FDA advisory committee recommendation against "modification of clinical progression" status for the drug.

10/06/2011 Deep Brain Stimulation (DBS) Ten Years Later

Researchers from Toronto recently found that motor improvement in patients who had DBS was sustained for up to 10 years. Dave Iverson spoke to one of the study’s authors, as well as a patient who had DBS 10 years ago and another who will soon have it.

08/25/2011 An Interview with Runner Sam Fox

Dave Iverson spoke to Team Fox runner Sam Fox about his decision to run/hike the entire 2,650-mile length of the Pacific Crest Trail to raise money for MJFF.

08/01/2011 Depression and Parkinson's Disease

Dr. Irene Richard from the University of Rochester talks about depression's impact on Parkinson's patients and where research stands in this field.

06/22/2011 The Exercise Help Line

Terry Ellis, PT, PhD, NCS, Clinical Associate Professor at Boston University, introduces her exercise helpline, a resource for those who want to learn more about physical activity and PD. The number is 888-606-1688. Dave Iverson reports.

06/17/2011 Hot Topics Call: Exercise & PD - Part 1

On June 8, MJFF hosted a Hot Topics call on exercise and PD with Lisa Shulman, MD, Associate Professor of Neurology at the UMD School of Medicine. Part One includes a background of her exercise study and its overall objectives.

06/17/2011 Hot Topics Call: Exercise & PD - Part 2

On June 8, MJFF hosted a Hot Topics call on exercise and PD with Lisa Shulman, MD, Associate Professor of Neurology at the UMD School of Medicine. Part Two focuses on her study’s recruitment and results.

06/16/2011 What Forms of Exercise Help Most

Lisa Shulman, MD, Associate Professor of Neurology at the University of Maryland School of Medicine, discusses what forms of exercise help most.

06/14/2011 CoQ10 - A Patient's Perspective

In response to the halted NIH Coenzyme Q10 study, Dave Iverson spoke to two patients currently taking CoQ10.

06/08/2011 Why Exercise May Help Parkinson's Patients

Giselle Petzinger, MD, Assistant Professor of Neurology and Biokinesiology/Physical Therapy at the University of Southern California, discusses how exercise may help Parkinson's patients.

04/27/2011 Sohini Chowdhury talks with BIOtech NOW

Dan McGirt of BioTech Now interviewed Sohini Chowdhury for a podcast about MJFF research partnerships and how one can get involved with the Foundation.

04/20/2011 Clinical Trials Update Call, Part 1

Dr. Todd Sherer and Irene Hegeman Richard (Member, ESAB, and Associate Professor of Neurology and Psychiatry, University of Rochester School of Medicine and Dentistry) discussed three MJFF-funded clinical trials in the Bay Area.

04/20/2011 Clinical Trials Update Call, Part 2

In the second half of the call, Dr. Todd Sherer and Irene Hegeman Richard, MD, continued discussing three MJFF-funded clinical trials in the Bay Area.

02/23/2011 Clinical Trials Update Call, Part 2

In the second half of the call, Dr. Todd Sherer and Dr. David Standaert continue to discuss the four clinical trials. While the call focuses on trial sites in the NY tri-state area, the studies discussed have sites across the US and internationally.

02/23/2011 Clinical Trials Update Call, Part 1

On February 17th, Dr.Todd Sherer (Chief Program Officer, MJFF) and Dr. David Standaert (Interim Chair of Neurology and Director of the Comprehensive Neuroscience Center, UAB) discussed four clinical trials being funded by MJFF.

01/26/2011 Deep Brain Stimulation for PD Part 2

In the second of a two part series on the use of deep brain stimulation (DBS), Dr. Bill Marks continues to discuss the effectiveness of the surgical treatment and what it has to offer for PD patients today.

10/22/2010 Deep Brain Stimulation for Parkinson's Disease

In the first of a two part series on the use of deep brain stimulation (DBS), Dr. Bill Marks of UCSF discusses the effectiveness of the surgical treatment and what it has to offer for PD patients today.

09/14/2010 What Causes Parkinson's Disease?

In the second in MJFF's series on the possible causes of PD, Dave Iverson speaks to Dr. Andrew Singleton of the National Institute of Aging about the role of genetic factors.

07/13/2010 What Causes Parkinson's Disease?

In the first of a two part series on the possible causes of PD, Dave Iverson talks to Dr. William Langston of the Parkinson's Institute about the current state of research in this area, with a special focus on environmental risk factors.

07/08/2010 Building the Case for a PD Drug Target

Brian Fiske, PhD, associate director of research programs at MJFF, discusses the role of the Foundation's Target Validation program in advancing promising ideas through the early stages of PD drug development.

06/22/2010 A Multidisciplinary Approach to PD Science

Dave Iverson talks to Andy Grove, co-founder of Intel and senior advisor to MJFF about the need for a multidisciplinary approach to developing therapies using neurotrophic factors.

06/01/2010 Prioritizing Parkinson's Research

MJFF's Vice President of Research Programs Todd Sherer and Dave Iverson discuss MJFF's strategy for prioritizing PD research.

05/18/2010 The Impact of Depression on PD

Irene Hegeman Richard, MD, of the University of Rochester School of Medicine and Dentistry, discusses the impact of depression on people living with Parkinson's.

05/04/2010 Accelerating PD Research

MJFF CEO Katie Hood talks to David Iverson about the Foundation's unique role in the PD research field and upcoming MJFF initiatives.

04/21/2010 Biomarkers and PD

Ken Marek, MD, of the Institute for Neurodegenerative Disorders talks biomarkers with David Iverson.